Amatheon Animal Health Revenue and Competitors

Miami, FL USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Amatheon Animal Health's estimated annual revenue is currently $12.5M per year.(i)
  • Amatheon Animal Health's estimated revenue per employee is $201,000

Employee Data

  • Amatheon Animal Health has 62 Employees.(i)
  • Amatheon Animal Health grew their employee count by 15% last year.

Amatheon Animal Health's People

NameTitleEmail/Phone
1
ControllerReveal Email/Phone
2
Director OperationsReveal Email/Phone
3
Director Information TechnologyReveal Email/Phone
4
Territory Sales ManagerReveal Email/Phone
5
Logistics ManagerReveal Email/Phone
6
Customer Service ManagerReveal Email/Phone
7
Associate Account ManagerReveal Email/Phone
8
Technical Adviser and Software Development ManagerReveal Email/Phone
9
Territory Sales ManagerReveal Email/Phone
10
Territory Sales ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$32.2M160N/AN/AN/A
#2
$15.1M7523%N/AN/A
#3
$341.9M1701N/AN/AN/A
#4
$16.7M8343%N/AN/A
#5
$10.9M54-4%N/AN/A
#6
$11.3M56-2%N/AN/A
#7
$211.7M12974%N/AN/A
#8
$29.1M1455%N/AN/A
#9
$9.4M47-2%N/AN/A
#10
$11.9M59-8%N/AN/A
Add Company

What Is Amatheon Animal Health?

Established in 2002, Amatheon is the leading veterinary supplier of “Cross-Over Medications™” in the nation. Its primary focus is to provide every specialty veterinary hospitals in the country with a complete product line of brand and generic medications. Fully licensed and bonded to operate as a nationwide human and veterinary pharmaceutical distributor, Amatheon has increased its controlled substance market share year over year since inception. For more information, visit www.amatheon.com.

keywords:N/A

N/A

Total Funding

62

Number of Employees

$12.5M

Revenue (est)

15%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$35M6217%N/A
#2
$14M6222%N/A
#3
$11.8M62-2%N/A
#4
$8.5M6321%N/A
#5
$14.2M6334%N/A